Source disclosure: January 21, 2026
TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, Jan 21 (Pulse News Wire) – Towa Pharmaceutical CO.,LTD. (4553.T) and Otsuka Pharmaceutical Co., Ltd.
Signed a basic agreement aimed at stabilizing the supply of certain pharmaceutical products. Under the deal, Towa will take over manufacturing of some of Otsuka's long-standing drugs and utilize Otsuka’s licenses for strategic product development.
This collaboration seeks to address ongoing issues with drug shortages and ensure stable supplies of essential medicines. The agreement is expected to have a minor impact on Towa's fiscal year ending March 2026 but could contribute significantly to long-term performance improvements through leveraging both companies' strengths.
Towa views this partnership as a crucial step towards realizing its vision of creating a sustainable ecosystem for supplying essential medications.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing